Understanding Cancer Care · Ovarian Cancer

Ovarian cancer: making sense of the diagnosis and the road ahead.

Ovarian, fallopian tube and primary peritoneal cancers are closely related and treated the same way. Surgery and chemotherapy remain central, and genetic results now open up maintenance treatments that keep the disease away for longer.

READING YOUR REPORT

Three results that shape the plan

Cell typeWhich cells the cancer came from — most often high-grade serous.
BRCA / HRDGene and repair tests that decide whether PARP-inhibitor tablets can be used after chemotherapy.
StageHow far it has spread, usually confirmed during surgery.

This page is general education, not medical advice. Decisions about your care belong with your treating doctor. Full disclaimer

KNOW YOUR DIAGNOSIS

What kind of ovarian cancer is it?

"Ovarian cancer" covers several diseases that look and behave differently. The cell type guides both surgery and medicines.

TYPEWHAT IT MEANSTREATMENTS USUALLY DISCUSSED
High-grade serousThe most common type; often begins in the fallopian tube and is found at a later stage.Surgery and platinum chemotherapy, then maintenance with PARP inhibitors and/or bevacizumab
Clear cell & endometrioidSometimes linked to endometriosis; clear cell is seen more often in Asian women.Surgery is key; chemotherapy depends on stage
Low-grade serous & mucinousSlower-growing and less sensitive to standard chemotherapy.Surgery; hormone therapy is an option for some low-grade serous cancers
Germ cell & stromalRare; germ cell tumours mostly affect younger women.Fertility-sparing surgery is often possible; germ cell tumours respond very well to chemotherapy

OTHER WORDS YOU MAY SEE

CA-125

A blood marker used to track response and follow-up.

Debulking

Surgery aiming to remove all visible cancer in the abdomen.

Platinum-sensitive

The cancer responded well to platinum chemotherapy; guides later choices.

Primary peritoneal

Starts in the abdominal lining; treated like ovarian cancer.

Staging

How far has it spread?

Staging (the FIGO system) is usually confirmed during surgery, when the surgeon can see and sample the abdomen.

I

In one or both ovaries or tubes.

II

Spread to other organs within the pelvis.

III

The abdominal lining or lymph nodes. The most common stage at diagnosis.

IV

Beyond the abdomen, or inside organs such as the liver.

Standard care

The standard treatment pathway

Most women have surgery and chemotherapy, in either order. Maintenance treatment afterwards aims to delay the cancer's return.

TREATS THE AREA

Local treatment

Surgery — staging and removal of as much cancer as possible, ideally by a gynaecological oncologist.

Radiotherapy — used only occasionally, for example to ease symptoms from a single area.

TREATS THE WHOLE BODY

Systemic treatment

Chemotherapy — usually platinum-based; sometimes given before surgery to shrink the disease.

Maintenance therapy — PARP-inhibitor tablets and/or bevacizumab after a good response.

Newer options — antibody-drug conjugates and trials for recurrent disease.

OUR APPROACH

Where CELLAAX fits in

We do not replace your oncologist. We review your case, share findings with your treating team, and help you weigh supportive options.

3 STEPS
01

Review

A doctor reads your reports, scans and treatment history.

02

Coordinate

With your consent, we write to your oncologist before anything is added.

03

Support

A written supportive-care plan that fits around your main treatment.

THERAPIES

Built on our 7 principles

Every plan draws on all seven principles at once, tuned to your diagnosis. Your doctor selects and sequences the therapies, and agrees them with your oncologist before anything starts.

7 PRINCIPLES · 37 THERAPIES
PRINCIPLE 1

Non-toxic therapies

Precision Molecular Approach · Thermal Energy Therapies

PRINCIPLE 2

Immunomodulation

Bio-Immunotherapy

PRINCIPLE 3

Full spectrum nutrition

Biological Therapies · Metabolic Therapies · Therapeutic Nutrition

PRINCIPLE 4

Detoxification

Detoxification Therapies

PRINCIPLE 5

Oxygenation

Oxygen Therapies

PRINCIPLE 6

Restore the microbiome

Anti-Microbial Protocols

EARLY SIGNS

Noticed a change?

Most ovarian cancer changes are not cancer, but none should be ignored. See a doctor promptly — even if your last mammogram was clear.

  • Persistent abdominal bloating, swelling or feeling full quickly
  • Pelvic or lower abdominal pain and discomfort
  • Changes in bowel habits or frequent urination
  • Unexplained fatigue or unexpected weight loss
ALREADY DIAGNOSED?

Take our questionnaire to determine your next step.

QUESTIONS

Common questions

What causes ovarian cancer?

The exact cause is not always clear, but risk factors include inherited genetic mutations (BRCA1/BRCA2), increasing age, family history, and reproductive history.

How does CA-125 help in monitoring?

CA-125 is a blood protein. High levels can indicate ovarian cancer activity, and monitoring changes over time helps evaluate how well treatments are working.

What integrative therapies complement ovarian cancer treatment?

CELLAAX provides supportive biological IV therapies, therapeutic nutrition, hyperthermia, and immune support to help manage fatigue, protect healthy tissues, and improve overall resilience.

How can I get started with CELLAAX?

You can book a free consultation directly with our clinical team to review your reports and discuss a personalized integrative care plan.

A Cellaax care team reviewing a patient's integrative cancer care plan together in a bright clinic

Ready to discuss your ovarian cancer diagnosis?

Book a free consultation. Our doctors will review your reports and explain how integrative care fits into your journey.

WhatsApp+60 10-968 3 968
Emailinfo@cellaaxic.com
VisitPetaling Jaya, Selangor
HoursMon–Fri 9am–6pm · Sat 9am–1pm
WhatsApp us